Skip to main content
Top
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Modifiable cardiovascular risk factors in adults aged 40–79 years in Germany with and without prior coronary heart disease or stroke

Authors: Julia Truthmann, Markus A. Busch, Christa Scheidt-Nave, Gert B. M. Mensink, Antje Gößwald, Matthias Endres, Hannelore Neuhauser

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Control of modifiable cardiovascular disease (CVD) risk factors has substantially reduced CVD mortality, but risk factor levels in populations may change and need continuous monitoring. This study aims to provide current estimates of the prevalence of these risk factors in Germany according to sex and history of coronary heart disease (CHD) or stroke.

Methods

The analyses were based on data from the German Health Interview and Examination Survey for Adults (DEGS1; age 40–79 years, n = 5101), which is a cross-sectional population-based examination survey. CVD risk factors were defined according to recommendations in the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice 2012.

Results

The mean age was 57 years and 52 % were female; 493 participants had prior CHD and 163 participants a prior stroke. The overall prevalence of behavioural risk factors ranged from 17.9 % for high risk alcohol consumption to 90 % for low vegetable intake. Blood pressure ≥ 140/90 mmHg was found in 21 % and 69 % had total cholesterol ≥ 5.0 mmol/l. Only 16 % met the targets for five behavioural factors combined (smoking, physical activity, fruit intake, alcohol intake and obesity), 13 % of those with and 16 % of those without CHD or stroke. The prevalences of most behavioural risk factors were higher among men compared to women.

Conclusions

There is a high prevention potential from modifiable cardiovascular risk factors in the general population aged 40–79 years in Germany and among those with prior CHD or stroke. Risk factors are often co-occurring, are interrelated and require combined educational, behavioral, medical and policy approaches.
Appendix
Available only for authorised users
Literature
1.
go back to reference European Heart Network and European Society of Cardiology. European Cardiovascular Disease Statistics. 2012. European Heart Network and European Society of Cardiology. European Cardiovascular Disease Statistics. 2012.
2.
go back to reference King DE, Mainous 3rd AG, Geesey ME. Turning back the clock: adopting a healthy lifestyle in middle age. Am J Med. 2007;120:598–603.CrossRefPubMed King DE, Mainous 3rd AG, Geesey ME. Turning back the clock: adopting a healthy lifestyle in middle age. Am J Med. 2007;120:598–603.CrossRefPubMed
3.
go back to reference Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–701.CrossRefPubMed Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–701.CrossRefPubMed
4.
go back to reference Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011;32:2143–52.CrossRefPubMedPubMedCentral Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011;32:2143–52.CrossRefPubMedPubMedCentral
5.
go back to reference Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929–40.CrossRefPubMed Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373:929–40.CrossRefPubMed
6.
go back to reference Scheidt-Nave C, Kamtsiuris P, Gößwald A, Holling H, Lange M, Busch M, et al. German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12:730.CrossRefPubMedPubMedCentral Scheidt-Nave C, Kamtsiuris P, Gößwald A, Holling H, Lange M, Busch M, et al. German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12:730.CrossRefPubMedPubMedCentral
7.
go back to reference Gößwald A, Lange M, Dölle R, Hölling H. The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): Participant recruitment, fieldwork, and quality management. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:611–9.CrossRefPubMed Gößwald A, Lange M, Dölle R, Hölling H. The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): Participant recruitment, fieldwork, and quality management. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:611–9.CrossRefPubMed
8.
go back to reference Kamtsiuris P, Lange M, Hoffmann R, Schaffrath Rosario A, Dahm S, Kuhnert R, et al. The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): Sample design, response, weighting and representativeness. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:620–30.CrossRefPubMed Kamtsiuris P, Lange M, Hoffmann R, Schaffrath Rosario A, Dahm S, Kuhnert R, et al. The first wave of the German Health Interview and Examination Survey for Adults (DEGS1): Sample design, response, weighting and representativeness. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:620–30.CrossRefPubMed
9.
go back to reference Krug S, Jordan S, Mensink GBM, Müters S, Finger J, Lampert T. Physical activity : Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:765–71.CrossRefPubMed Krug S, Jordan S, Mensink GBM, Müters S, Finger J, Lampert T. Physical activity : Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:765–71.CrossRefPubMed
10.
go back to reference Burger M, Mensink GBM. High alcohol consumption in Germany: results of the German National Health Interview and Examination Survey 1998. Public Health Nutr. 2004;7:879–84.CrossRefPubMed Burger M, Mensink GBM. High alcohol consumption in Germany: results of the German National Health Interview and Examination Survey 1998. Public Health Nutr. 2004;7:879–84.CrossRefPubMed
11.
go back to reference Chang E, Canchola A, Lee V, Clarke C, Purdie D, Reynolds P, et al. Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control. 2007;18:91–103.CrossRefPubMedPubMedCentral Chang E, Canchola A, Lee V, Clarke C, Purdie D, Reynolds P, et al. Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control. 2007;18:91–103.CrossRefPubMedPubMedCentral
12.
go back to reference WHO Global InfoBase team. The SuRF Report 2. Surveillance of chronic disease Risk Factors: Country-level data and comparable estimates. Geneva: World Health Organization; 2005. WHO Global InfoBase team. The SuRF Report 2. Surveillance of chronic disease Risk Factors: Country-level data and comparable estimates. Geneva: World Health Organization; 2005.
13.
go back to reference National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.
14.
go back to reference King DE, Mainous 3rd AG, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988–2006. Am J Med. 2009;122:528–34.CrossRefPubMed King DE, Mainous 3rd AG, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988–2006. Am J Med. 2009;122:528–34.CrossRefPubMed
15.
go back to reference Laccetti R, Pota A, Stranges S, Falconi C, Memoli B, Bardaro L, et al. Evidence on the prevalence and geographic distribution of major cardiovascular risk factors in Italy. Public Health Nutr. 2013;16:305–15.CrossRefPubMed Laccetti R, Pota A, Stranges S, Falconi C, Memoli B, Bardaro L, et al. Evidence on the prevalence and geographic distribution of major cardiovascular risk factors in Italy. Public Health Nutr. 2013;16:305–15.CrossRefPubMed
16.
go back to reference Erdine S, Redon J, Bohm M, Ferri C, Kolloch R, Kreutz R, et al. Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol. 2013;20:786–92.CrossRefPubMed Erdine S, Redon J, Bohm M, Ferri C, Kolloch R, Kreutz R, et al. Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol. 2013;20:786–92.CrossRefPubMed
17.
go back to reference Scheidt-Nave C, Du Y, Knopf H, Schienkiewitz A, Ziese T, Nowossadeck E, et al. Prevalence of dyslipidemia among adults in Germany : Results of the German health interview and examination survey for adults (DEGS 1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:661–7.CrossRefPubMed Scheidt-Nave C, Du Y, Knopf H, Schienkiewitz A, Ziese T, Nowossadeck E, et al. Prevalence of dyslipidemia among adults in Germany : Results of the German health interview and examination survey for adults (DEGS 1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:661–7.CrossRefPubMed
18.
go back to reference Robinson JG, Wang S, Smith BJ, Jacobson TA. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol. 2009;53:316–22.CrossRefPubMed Robinson JG, Wang S, Smith BJ, Jacobson TA. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol. 2009;53:316–22.CrossRefPubMed
19.
go back to reference Steinhagen-Thiessen E, Bramlage P, Losch C, Hauner H, Schunkert H, Vogt A, et al. Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol. 2008;7:31.CrossRefPubMedPubMedCentral Steinhagen-Thiessen E, Bramlage P, Losch C, Hauner H, Schunkert H, Vogt A, et al. Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol. 2008;7:31.CrossRefPubMedPubMedCentral
20.
go back to reference Stranges S, Guallar E. Cardiovascular disease prevention in women: a rapidly evolving scenario. Nutr Metab Cardiovasc Dis. 2012;22:1013–8.CrossRefPubMed Stranges S, Guallar E. Cardiovascular disease prevention in women: a rapidly evolving scenario. Nutr Metab Cardiovasc Dis. 2012;22:1013–8.CrossRefPubMed
21.
go back to reference Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H, Canadian Cardiovascular Outcomes Research T. Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003;19:1249–59.PubMed Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H, Canadian Cardiovascular Outcomes Research T. Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003;19:1249–59.PubMed
22.
go back to reference Courtenay WH. Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Soc Sci Med. 2000;50:1385–401.CrossRefPubMed Courtenay WH. Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Soc Sci Med. 2000;50:1385–401.CrossRefPubMed
23.
24.
go back to reference van Wyk JT, van Wijk MA, Sturkenboom MC, Moorman PW, van der Lei J. Identification of the four conventional cardiovascular disease risk factors by Dutch general practitioners. Chest. 2005;128:2521–7.CrossRefPubMed van Wyk JT, van Wijk MA, Sturkenboom MC, Moorman PW, van der Lei J. Identification of the four conventional cardiovascular disease risk factors by Dutch general practitioners. Chest. 2005;128:2521–7.CrossRefPubMed
25.
go back to reference Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed). 1981;282:1847–51.CrossRef Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed). 1981;282:1847–51.CrossRef
27.
go back to reference Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003;361:717–25.CrossRefPubMed Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003;361:717–25.CrossRefPubMed
Metadata
Title
Modifiable cardiovascular risk factors in adults aged 40–79 years in Germany with and without prior coronary heart disease or stroke
Authors
Julia Truthmann
Markus A. Busch
Christa Scheidt-Nave
Gert B. M. Mensink
Antje Gößwald
Matthias Endres
Hannelore Neuhauser
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1929-5

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue